María López

Primary Chemoradiotherapy Treatment (PCRT) for HER2+ and Triple Negative Breast Cancer Patients: A Feasible Combination

L. Garcia-Cañamaque, C. Rubio, O. Hernando, 2022, Cancers.

Complete response with fotemustine and bevacizumab after early progression following radiotherapy and temozolomide treatment in patient with glioblastoma multiforme

O. Calvo, J. Gómez, María López, 2015 .

Neoadjuvant Chemoradiation for Unfavourable Breast Cancer Patients: A Prospective Cohort Study

N. Ramirez, P. Letón, L. Garcia-Cañamaque, 2019 .